| Value | ₹67.10 Cr |
|---|
BSE filing, NSE: NATCOPHARM. Summary written from the filing by ALFA Finder's alert engine.
Natco Pharma Ltd: key numbers
- Share price
- ₹793.00
- Market cap
- ₹15,556 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.6×Sector 46.1×
- Promoter holding
- 49.39%-0.03% QoQ
- FII holding
- 15.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natco Pharma Ltd
All →Natco Pharma Capital Structure Change
Natco Pharma's ₹1,279.4 Crore rights issue closed on October 22, 2026. Shares were priced at ₹750 each on a ₹2 face value.
- Value
- ₹1,279 Cr
Natco Pharma Product Launch
Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.
Natco Pharma Other Announcement
Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.
Natco Pharma Fund Raise of ₹2,000 Cr
Natco Pharma shareholders approved fund raising of up to Rs. 2,000 Crore through various instruments, along with other routine AGM resolutions.
- Value
- ₹2,000 Cr
Natco Pharma Annual General Meeting
Natco Pharma held its 43rd Annual General Meeting on September 30, 2026. Shareholders approved all agenda items, including a fund-raising authorisation limit of Rs. 2,000 Crore.
Natco Pharma Annual General Meeting
Natco Pharma Limited conducted its 43rd Annual General Meeting on September 30, 2026. Shareholders considered a proposal to raise up to ₹2,000 Crore through various equity instruments.
- Value
- ₹2,000 Cr
Other share pledge announcements
All →TVS Holdings Share Pledge
Promoter trusts pledged TVS Holdings shares to JM Financial entities as security for credit facilities. The pledge covers 16,75,800 shares, or 8.28% of total share capital.
Paisalo Digital Share Pledge
Equilibrated Venture Cflow, a promoter group entity, pledged 2.98 crore Paisalo shares on October 26, 2026. The pledge secures a Rs.25 Crore third-party loan from Jio Credit.
- Value
- ₹25.00 Cr
Paisalo Digital Share Pledge
Promoter group entity Equilibrated Venture Cflow pledged 1,03,63,523 shares, valued at Rs.79.59 Crore, on October 26, 2026. Promoter holding stays at 20.64% after the pledge.
- Value
- ₹79.59 Cr
Billionbrains Garage Ventures Share Pledge
Golden Oak Trust (promoter group) pledged 1,50,000 shares of Billionbrains Garage Ventures to Aditya Birla Capital Ltd. The pledge covers 0.24% of total share capital, dated 19-Oct-2026.
Medplus Health Services Share Pledge
Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).
Royal Sense Share Pledge
Royal Sense promoter Rishabh Arora released a pledge on 10,00,000 shares on September 17, 2026. A supporting letter corrects the post-event encumbered holding to nil.